Connect Biopharma Statistics Share Statistics Connect Biopharma has 55.58M
shares outstanding. The number of shares has increased by 0.18%
in one year.
Shares Outstanding 55.58M Shares Change (YoY) 0.18% Shares Change (QoQ) 0.18% Owned by Institutions (%) 5.12% Shares Floating 14.34M Failed to Deliver (FTD) Shares 1,592 FTD / Avg. Volume 0.87%
Short Selling Information The latest short interest is 102.42K, so 0.18% of the outstanding
shares have been sold short.
Short Interest 102.42K Short % of Shares Out 0.18% Short % of Float 0.29% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -4.88 and the forward
PE ratio is -0.32.
Connect Biopharma's PEG ratio is
0.07.
PE Ratio -4.88 Forward PE -0.32 PS Ratio 2.93 Forward PS 1.3 PB Ratio 0.83 P/FCF Ratio -3.13 PEG Ratio 0.07
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Connect Biopharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 11.46,
with a Debt / Equity ratio of 0.
Current Ratio 11.46 Quick Ratio 11.46 Debt / Equity 0 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $419.89K Profits Per Employee $-252.06K Employee Count 62 Asset Turnover 0.26 Inventory Turnover n/a
Taxes Income Tax 223K Effective Tax Rate -1.45%
Stock Price Statistics The stock price has increased by 40% in the
last 52 weeks. The beta is -0.08, so Connect Biopharma's
price volatility has been lower than the market average.
Beta -0.08 52-Week Price Change 40% 50-Day Moving Average 1.77 200-Day Moving Average 1.12 Relative Strength Index (RSI) 45.66 Average Volume (20 Days) 182,850
Income Statement In the last 12 months, Connect Biopharma had revenue of 26.03M
and earned -15.63M
in profits. Earnings per share was -0.28.
Revenue 26.03M Gross Profit 26.03M Operating Income -22.45M Net Income -15.63M EBITDA -21.79M EBIT -22.45M Earnings Per Share (EPS) -0.28
Full Income Statement Balance Sheet The company has 78.23M in cash and 178K in
debt, giving a net cash position of 78.05M.
Cash & Cash Equivalents 78.23M Total Debt 178K Net Cash 78.05M Retained Earnings -345.36M Total Assets 82.72M Working Capital 67.02M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -23.61M
and capital expenditures -750K, giving a free cash flow of -24.36M.
Operating Cash Flow -23.61M Capital Expenditures -750K Free Cash Flow -24.36M FCF Per Share -0.44
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -86.24% and -60.03%.
Gross Margin 100% Operating Margin -86.24% Pretax Margin -59.17% Profit Margin -60.03% EBITDA Margin -83.71% EBIT Margin -86.24% FCF Margin -93.58%
